Search research articles
Contact Us
Filters
Showing results (961-970 of 2,726) with videos related to
Page
of 273
Sort By:
Bioanalysis
|
November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry
Graham Lappin, Mark Seymour
Bioanalysis
|
November 19, 2010
Regulatory observations in bioanalytical determinations
C T Viswanathan
Bioanalysis
|
November 19, 2010
Interview: Interview with Professor Malcolm Rowland
Malcolm Rowland
Bioanalysis
|
November 19, 2010
Development of 2D chiral chromatography with accelerator mass spectrometry for quantification of (14)C-labeled R- and S-verapamil in plasma
M Simpson, G Lappin, B J Keely
Bioanalysis
|
November 19, 2010
Microdosing in early lead discovery
A P Jekunen, E K J Pauwels, K J A Kairemo
Bioanalysis
|
November 19, 2010
Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical (14)C measurements
John S Vogel, Jason A Giacomo, Tim Schulze-König, et al.
Bioanalysis
|
November 19, 2010
Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye
Sai H S Boddu, Sriram Gunda, Ravinder Earla, et al.
Bioanalysis
|
November 19, 2010
Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment
Ami C Bautista, Danika Wullner, Mike Moxness, et al.
Bioanalysis
|
November 19, 2010
Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS/MS
Eliza N Fung, Naiyu Zheng, Mark E Arnold, et al.
Bioanalysis
|
November 19, 2010
Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges
Sarah M R Wille, Maria Del Mar Ramírez-Fernandez, Nele Samyn, et al.
Page
of 273
Search research articles
Search
Showing results (961-970 of 2,726) with videos related to
Sort By:
Page
of 273
Bioanalysis
|
November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry
Graham Lappin, Mark Seymour
Bioanalysis
|
November 19, 2010
Regulatory observations in bioanalytical determinations
C T Viswanathan
Bioanalysis
|
November 19, 2010
Interview: Interview with Professor Malcolm Rowland
Malcolm Rowland
Bioanalysis
|
November 19, 2010
Development of 2D chiral chromatography with accelerator mass spectrometry for quantification of (14)C-labeled R- and S-verapamil in plasma
M Simpson, G Lappin, B J Keely
Bioanalysis
|
November 19, 2010
Microdosing in early lead discovery
A P Jekunen, E K J Pauwels, K J A Kairemo
Bioanalysis
|
November 19, 2010
Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical (14)C measurements
John S Vogel, Jason A Giacomo, Tim Schulze-König, et al.
Bioanalysis
|
November 19, 2010
Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye
Sai H S Boddu, Sriram Gunda, Ravinder Earla, et al.
Bioanalysis
|
November 19, 2010
Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment
Ami C Bautista, Danika Wullner, Mike Moxness, et al.
Bioanalysis
|
November 19, 2010
Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS/MS
Eliza N Fung, Naiyu Zheng, Mark E Arnold, et al.
Bioanalysis
|
November 19, 2010
Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges
Sarah M R Wille, Maria Del Mar Ramírez-Fernandez, Nele Samyn, et al.
Page
of 273